Infertility Treatment and Breast Cancer Risk in Women with BRCA Pathogenic Variants: A Matched Case-Control Analysis - Top-Institutions - MDSpire

Infertility Treatment and Breast Cancer Risk in Women with BRCA Pathogenic Variants: A Matched Case-Control Analysis

  • By

  • Marta Seca

  • Jacek Gronwald

  • Tomasz Huzarski

  • Karen Glass

  • Amber Aeilts

  • Raymond H. Kim

  • Beth Karlan

  • Christian F. Singer

  • Andrea Eisen

  • Nadine Tung

  • Olufunmilayo Olopade

  • Louise Bordeleau

  • Pal Moller

  • William D. Foulkes

  • Susan L. Neuhausen

  • Fergus Couch

  • Tuya Pal

  • Robert Fruscio

  • Cezary Cybulski

  • Jan Lubinski

  • Shana Kim

  • Ping Sun

  • Steven A. Narod

  • Joanne Kotsopoulos

  • November 10, 2025

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    University of Toronto - Lunenfeld-Tanenbaum Research Institute
    University of Toronto - Lunenfeld-Tanenbaum Research Institute

    Toronto, Ontario

    Key Differentiators

    • Oncology
    • Genetics
    • Reproductive Medicine

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Genetic Counseling
    • Reproductive Endocrinology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Cancer Genetics
    • Oncology
    • Reproductive Medicine

  • #4

    The Institute of Cancer Research and Royal Marsden NHS Foundation Trust
    The Institute of Cancer Research and Royal Marsden NHS Foundation Trust

    London, England

    Key Differentiators

    • Cancer Genetics
    • Oncology
    • Reproductive Health

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology
    • Genetics
    • Reproductive Endocrinology

Original Source(s)

Infertility Treatment and Breast Cancer Risk in Women with BRCA Pathogenic Variants: A Matched Case-Control Analysis

  • by Marta Seca, Jacek Gronwald, Tomasz Huzarski, Karen Glass, Amber Aeilts, Raymond H. Kim, Beth Karlan, Christian F. Singer, Andrea Eisen, Nadine Tung, Olufunmilayo Olopade, Louise Bordeleau, Pal Moller, William D. Foulkes, Susan L. Neuhausen, Fergus Couch, Tuya Pal, Robert Fruscio, Cezary Cybulski, Jan Lubinski, Shana Kim, Ping Sun, Steven A. Narod, Joanne Kotsopoulos

  • November 10, 2025

Related Content

Then and Now: What We Have Learned From the WHI

Reply to the Letter to the Editor: Radiation exposure and screening yield by digital breast tomosynthesis compared to mammography—results of the TOSYMA trial breast density related

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors: An Integrative Review

Sexual dysfunction is a lasting effect of treatment and can impact the quality of life of breast cancer survivors. This review examined the impact of different levels (none/low, moderate, and high) of physical activity on sexual outcomes in breast cancer survivors.